Kansas health regulators issued a joint warning on Wednesday, Feb. 25, saying many retail IV therapy clinics are likely violating the law and potentially endangering patients.
How integrated pharmaceutical manufacturing helps CDMOs simplify scale-up, reduce complexity, and move from raw materials to finished dosage forms faster.
Novo Nordisk is suing a Shrewsbury doctor who sells a cheaper compounded medicine version of its popular Ozempic and Wegovy ...
LIXTE Biotechnology Holdings (NASDAQ: LIXT) announced an expansion of its collaboration with The University of Texas MD ...
GLP-1 medications have changed the conversation around weight management and metabolic health. When prescribed appropriately, ...
Jay Bregman, CEO and co-founder of Andel, discusses how FDA’s action signals a broader regulatory recalibration aimed at protecting intellectual property and explores the second-order effects.
As a physician, former U.S. Surgeon General, and former Indiana State Health Commissioner, my career has been guided by a ...
As a physician, former U.S. Surgeon General, and former Indiana State Health Commissioner, my career has been guided by a ...
An informational overview of Ivím Health's compounded semaglutide and tirzepatide telehealth program, including GLP-1 ID cost breakdown, weekly provider check-in structure, clinical claims analysis, a ...
Blue bin 0175 whirred along a conveyer belt in Fairview Health Services’ new automated pharmacy in Shoreview with a big job: ...
Jay Bregman, CEO and co-founder of Andel, discusses how pharmaceutical companies and digital health platforms may need to rethink commercialization strategies, shifting away from costly mass-market ...
The compounds have exploded in popularity, but big questions about safety and effectiveness are still unresolved.